Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Delayed Nasdaq
Other stock markets
 02:08:27 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.5511 USD -10.97% Intraday chart for Galecto, Inc. -11.57% -23.46%
May. 01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI
Apr. 29 Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GALECTO, INC.
Bio Therapeutic Drugs
-10.97%-11.57%-23.46%-75.62% - 16.78M
Bearish
Neutral
Bearish
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. Relative Strength Chart